Abstract
The aim of this Delphi study was to assess current perspectives on HR+/HER2- advanced breast cancer (aBC) treatment strategies among Nordic BC oncologists, and to gain broader understanding of the uptake and implementation of novel treatments.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have